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Abstract Thedurationof inpatientepisodesduetoCOPDandthe factors that affectithaverecentlybeenanobjectof
increasing attention, as the aim has been to shorten inpatient periods and thereby to cut health-care costs. All hospital
episodes of patients aged over 45 for a primary diagnosis of COPD equal or less than150 days in durationwere drawn
fromthetreatmentregistermaintainedby theNational Research andDevelopmentCentre forWelfare andHealth.The
lengths ofthese152 569 inpatientperiodswere analysed for sex, age and secondarydiagnosesbycovariance analysis.The
mean age ofmen atthebeginningofthehospital episodewas 70.6 years andthatofwomen 70.1years.Men accounted for
76.9% of allinpatientepisodes.Covariance analysis ofthe datawith age standardised as 70.5 yearsyielded ameanhospital
episode length of 8.9 (95% confidence interval (CI) 8.8^9.0) days.Themeanlength of hospital episodeswithout a second-
arydiagnosiswas 7.7 (95%CI 7.6^7.7) days andthatwitha secondarydiagnosiswas10.5 (95%CI10.5^10.6) days.Thelongest
inpatient episodeswere recorded for the patients with secondary diagnoses of pneumonia,14.7 (95% CI14.2^15.2) days,
and cerebral ischaemia,14.2 (95% CI13.5^14.9) days.Concurrent diseases prolonged the hospital episodes of COPD pa-
tients. Atthe beginning of a hospital episode, it is possible to estimate its duration and the need for differenttreatments
based onthe patient’s age and secondarydiagnoses.r2002 Elsevier Science Ltd.Allrights reserved.
Available online athttp://www.sciencedirect.com
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More and more hospital services are needed to treat
COPD in the oldest age groups of the population, and
this trend has been estimated to continue (1).The hospi-
tal episodes of COPD patients are often long and thus
contribute signi¢cantly to the costs of health care. In-
creasing attention has recently been paid to the length
of COPD patients’ hospital episodes and the factors that
contribute to it, with the ultimate aim of shortening
inpatient periods (2,3). The purpose of this study
was to analyse the correlation between COPD patients’
comorbidities and the length of their hospital episodes
based on a hospital discharge register. The results will
help us to estimate the period of inpatient treatment
neededby COPD patients withmultiple pathologies.Received1March 2002, accepted in revised form 20 August 2002.
Correspondence should be addressed to:DrTuija Kinnunen,Central
Ostrobothnian Central Hospital,Mariankatu16-20, FIN-67200
Kokkola, Finland. E-mail: tuija.kinnunen@kpshp.¢METHODS
The data of patients aged over 45 years concerning hos-
pital episodeswithCOPD as theprimarydiagnosis in the
years 1987^1998 were collected from the Finnish treat-
ment register maintained by the National Research and
Development Centre for Welfare and Health (ICD 9:
491, 492 and 496; ICD10: J41-44).There were altogether
153 390 hospital episodes of this kind. All hospital treat-
mentdays were counted as hospitalisation days, the days
of arrival and departure togethermaking up1day. Inpati-
ent episodes longer than 150 days were excluded from
analysis. Such long inpatient episodes numbered 832.
After these exclusions, a total of 152 569 hospital epi-
sodes remained, including 1 358 130 inpatient days.
The length of the hospital episode was recorded in
relation to thepatient’s sex, age and secondary diagnosis.
The patients were divided into age groups of 46^75
years and over 75 years. The secondary diagnoses
were coded into 11 categories, of which the ¢rst was
COPD without a secondary diagnosis. Each of the
other categories corresponded to one of the most
common diagnoses, except the last category, which was
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to determine the di¡erences between these categories.
RESULTS
The average age of men at the beginning of the hospital
episodewas 70.6 years and thatof women 70.1years.Men
accounted for 76.9% of all hospital episodes. The mean
duration of hospital episodes was 8.7 (SD 11.0) days for
men and 9.5 (SD11.9) days for women. Subjects aged over
75 accounted for 29.1% of the inpatient episodes. A sec-
ondary diagnosis was recorded for 43.1% of the hospital
episodes primarily due to COPD in 1987^1998. Second-
ary diagnoses were recorded for 42.0% of the COPDpa-
tients aged 46^75 years and 45.8% of those aged over 75
years.Themost common secondary diagnoses were car-
diovascular diseases, which occurred in18.5% of all hos-
pital episodes.
Covariance analysis
The mean length of hospital episodes without a second-
ary diagnosis was 7.5 (95% con¢dence interval (CI) 7.5^
7.6) for men and 8.1 (95% CI 7.9^8.2) for women.When a
secondary diagnosis was present, the corresponding
mean length was10.3 (95% CI10.2^10.4) for men and11.4
(95% CI 11.2^11.6) for women. The longest inpatient epi-
sodes were recorded for men with pneumonia, 14.8
(95% CI14.3^15.3) days, and cerebral ischaemia,13.9 (95%
CI 13.2^14.7) days, and for women with pneumonia, 14.5
(95% CI13.4^15.6) days, and cerebral ischaemia,15.8 (95%
CI13.8^17.9) days.
Covariance analysis of the data with age standardised
as 70.5 years showed the mean duration of hospitalTABLE 1. Number of hospital episodes for COPD during1987^
ondarydiagnosis and their length as standardised for age bycova
N
No secondarydiagnosis 86744
Pneumonia and in£uenza 2159
Asthma 8380
Lungcancer 959
Other pulmonarydisease 8048
Coronarydisease 11177
Cerebral ischaemia 978
Other vasculardisease 16145
Diabetes 1726
Other than lungcancer 1594
Other secondarydiagnosis 14 659
Total 152 569episodes in the whole series to be 8.9 (95% CI 8.9^9.0)
days. Without a secondary diagnosis, the duration of
inpatient treatment was 7.7 (95% CI 7.6^7.7) days, while
with a secondary diagnosis it was 10.5 (95% CI 10.5^10.6)
days.The inpatient episodes with pneumonia and cerebral
ischaemia as secondary diagnoses were longest (Table 1).
All secondary diagnoses prolonged the inpatient periods
signi¢cantly.
Covariance analysis also showed the duration of hospi-
tal episodes of the patients aged 46^75 years without a
secondary diagnosis to be 7.2 (95% CI 7.2^7.3) days and
the corresponding duration among those aged over 75
to be 8.7 (95% CI 8.5^8.8) days. The corresponding ¢g-
ures for the patients with a secondary diagnosis were
9.7 (95% CI 9.6^9.8) in the younger group and 12.5 (95%
CI 12.3^12.6) in the older group. The longest inpatient
episodes in theyounger agegroupswere duepneumonia,
13.2 (95% CI12.6^13.7) days, and cerebral ischaemia,12.1
(95% CI11.3^12.9) days.The longest inpatient episodes in
the older age group were similarly recorded for those
withpneumonia,17.8 (95%CI16.9-18.8) days, and cerebral
ischaemia,17.8 (95% CI16.5^19.0) days.
DISCUSSION
The Finnish Hospital Discharge Register covers all Fin-
nish hospitals, both private and public. Its reliability has
been found to be good, with up to 95% correspondence
between the register and the patient records (4).During
the study period1987^1998, only two diagnostic classi¢-
cationswereused,whichmeans that the diagnostic prac-
tices were probably relatively uniform.
During1972^1992, inpatientepisodes due toCOPDin-
creased among both men and women in Finland. The
overall number of inpatient episodes was highest among1998 and their average duration as days of treatment by sec-
riance analysis
Meanlength Standardised oftreatment
length oftreatment (95% CI)
7.6 7.7 (7.6^7.7)
14.9 14.7 (14.2^15.2)
9.0 9.4 (9.2^9.6)
9.4 9.4 (8.7^10.1)
10.3 10.5 (10.2^10.7)
10.6 10.3 (10.1^10.5)
14.5 14.2 (13.5^14.9)
10.6 10.4 (10.3^10.6)
9.9 9.8 (9.2^10.3)
11.0 10.7 (10.2^11.3)
10.8 10.9 (10.7^11.0)
8.9 8.9 (8.8^9.0)
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clearly among women during the follow-up period.
Altogether16% of the hospital episodeswere forwomen
(5). According to our ¢ndings, the percentage of hospital
episodes among women increased up to 23%, probably
due to the increase of smoking among women.Within
50 years, the share of smoking women has doubled,
while the share of smokingmenhas decreased in Finland.
InCanada, thenumberof hospital episodes due toCOPD
among the population aged over 75 increased, and that
among women even doubled, during the period 1982^
1994 (1).
The length of hospital episodes due toCOPDhasbeen
reported to vary from 6.4 to 8.7 days in di¡erent series
(1,6). Our results agree with those of Mushlin et al. Ac-
cording to our ¢ndings, high age and comorbidities pro-
longed the duration of hospital episodes, which
phenomenon has also been previously reported among
COPDpatients (7). In an Italian study, themost common
comorbidities in patients with serious COPD were hy-
pertension (28%), diabetes (14%) and coronary artery
disease (10%) (8). According to Incalz, the duration of
COPD patients’ hospital episodes was signi¢cantly af-
fected by the presence of more than three concurrent
diseases (9).
COPD is one of the risk factors of pneumonia. Ac-
cording to Marrie et al., one-third of pneumonia patients
had COPD (10). Exacerbation of COPD is often due to a
viral or bacterial infection, whichmaydevelop intopneu-
monia. Systemic corticosteroid treatment administered
to counteract the exacerbation of COPD has also been
found to increase theriskof pneumonia (11). According to
our ¢ndings,COPDpatients required aweekof inpatient
treatment due to exacerbation of COPD without pneu-
monia, while concurrent pneumonia doubled the dura-
tion of hospital treatment. COPD patients often have
extremely poor pulmonary function and hypoxemia,
and it is hence reasonable to prepare for a 2-week
hospital episode in the case of a COPD patient with
pneumonia.
According to our observations, cardiovascular dis-
eases are quite common among COPD patients, prob-
ably due to the high prevalence of smoking, which is a
risk factor for both.When cardiovascular diseases were
present concurrently with COPD, they signi¢cantly pro-
longed hospital episodes.The patients with a secondary
diagnosis of coronary or other vascular disease required
inpatient periods nearly 3 days longer than the others. It
is well known that COPDhas a signi¢cant impact on car-
diovascular function and vice versa. According to Vilk-
man et al., coronary and other vascular diseases were
the most common causes of death (37%) among COPD
patients (12). In the case of patients with cerebral
ischaemia, the reason for the prolonged need for inpati-
ent treatment upon exacerbation of COPD is probably
the di⁄culty of using inhalators and respiratory devices.The hospital episodes due to exacerbation of COPD
were always prolonged when the patient had a second-
ary diagnosis. Among the study population, diabetes
was one of the most common secondary diagnoses,
and it increased the length of hospital episodes by
about 2 days. Although hyperglycaemia is themost com-
mon side-e¡ect of cortisone treatment, systemic
corticosteroid treatment has been shown to shorten
the duration of inpatient treatment for exacerbation of
COPD.
Our ¢ndings suggest that, based on the COPD pa-
tient’s sex, age and comorbidities, it is possible to esti-
mate the duration of hospital treatment and the
necessary therapeuticmeasures (monitoring, home hos-
pital, inpatient unit, ICU)/need for after-care upon ad-
mission into the emergency unit, as especially
pneumonia and cerebral ischaemia almost double the
hospital episode. The discharge of COPD patients with
concurrent pneumonia or cerebral ischaemia cannot be
unduly hastened, to avoid the revolving door phenomen-
on. COPD patients without comorbidities could be tar-
geted with increasing precision (and increasingly
reliability) to short-term emergency care, monitoring or
supervised home care/home hospital, which has been
the obvious goal recently (2).
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